Indo Us Bio Tech Board Meeting on May 29, 2026

• Indo Us Bio Tech intimated a board meeting on May 29, 2026 to approve FY26 and Q4 results.
• The agenda includes audited financial results for year and quarter ended March 31, 2026.
• The trading window closure for the company is effective from April 1 to May 30, 2026.
• The disclosure is a mandatory regulatory filing under SEBI LODR Regulations 29 and 33.